Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Assets Average (2020 - 2025)

Historic Assets Average for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $361.7 million.

  • Arcutis Biotherapeutics' Assets Average fell 1799.12% to $361.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $361.7 million, marking a year-over-year decrease of 1799.12%. This contributed to the annual value of $345.1 million for FY2024, which is 1269.67% down from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Assets Average of $361.7 million as of Q3 2025, which was down 1799.12% from $348.3 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' Assets Average's 5-year high stood at $479.1 million during Q4 2022, with a 5-year trough of $306.8 million in Q3 2023.
  • In the last 5 years, Arcutis Biotherapeutics' Assets Average had a median value of $393.1 million in 2024 and averaged $389.3 million.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 9068.2% in 2021, then crashed by 3379.96% in 2023.
  • Quarter analysis of 5 years shows Arcutis Biotherapeutics' Assets Average stood at $397.6 million in 2021, then grew by 20.5% to $479.1 million in 2022, then tumbled by 33.8% to $317.2 million in 2023, then grew by 23.95% to $393.1 million in 2024, then dropped by 7.99% to $361.7 million in 2025.
  • Its last three reported values are $361.7 million in Q3 2025, $348.3 million for Q2 2025, and $346.5 million during Q1 2025.